The content you are trying to access is intended
for healthcare professionals only. 

Are you a healthcare professional?
The content you are about to view is intended for consumers. You are being redirected.
The content you are about to view is intended for healthcare professionals. You are being redirected.

Where Nutrition Becomes Therapy

New Horizons for Nutritional Therapy

In our established business areas – Consumer Care and Medical Nutrition – we already have a comprehensive range of products that help correct or improve nutritional status that are important – and in some cases – clinically proven to be a vital part of recovery or health management.

Now, new opportunities are emerging based upon scientific advances (omics) being made about both the nature of disease and the potential of nutritionally related innovations to directly impact them in a clinically proven way, with a known mode of action. This creates the potential to bring forward innovations with a more direct and clinically proven therapeutic impact. That’s why we set up an additional business area: Novel Therapeutic Nutrition.


  • Nutritional Therapies
    We are committed to be the company ‘where nutrition becomes therapy’ across all areas of our business, Consumer Care, Medical Nutrition and Novel Therapeutic Nutrition.

In Consumer Care are combining science-based innovation and global brand building skills to address consumers’ unmet and emerging needs for nutritional solutions that help them live healthier lives. Consumers - whom are increasingly health aware and informed - buy our products in pharmacies, retail outlets or via the internet. We are focused upon the fast developing areas of healthy aging, healthy growing, gut health and obesity care.

Our Medical Nutrition portfolio includes products and services recommended by healthcare professionals (HCPs) for patients with specific nutritional and dietary needs related to illnesses, disease states or special challenges of different life stages. Our products are most relevant to the institutional sector – including hospitals, long-term care facilities and homecare. The current portfolio is focused upon Inborn Errors of Metabolism, Pediatric Care & Allergy, Acute Care, Adult Care, Critical Care & Devices and Oncology Care.

In Novel Therapeutic Nutrition, we are investing in companies with a range of nutrition-based technology platforms aiming to bring forward clinically proven innovations, initially in the areas of brain and gastrointestinal health. In brain health and Alzheimer’s disease for example, we are supporting further clinical trials of a product, which helps the brain to process glucose needed for effective brain function.

And in gastrointestinal health, one of our initiatives is to invest in the development of microbiome therapeutics. These have the potential to address the underlying causes of many types of diseases by restoring the gut microbiota to a healthy state. This healthy state can be disrupted by different health conditions such as trauma or even drugs.

Nestlé Health Science is a new, innovative and fundamentally different type of company: we are a health science company focused upon advancing nutritional therapy to change the course of health – for people, patients and our partners in healthcare. It’s a compelling opportunity.